Tau dysfunction, such as increased phosphorylation and aggregation, has been correlated with many neurodegenerative diseases, including Alzheimer’s disease (AD) and related dementias [1,2]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.